Work

Phase II trial of irinotecan and metronomic temozolomide in patients with recurrent glioblastoma

Year: 2015

Type: article

Study design: Clinical Trial

Source: Anti-Cancer Drugs

DOI: 10.1097/cad.0000000000000314

Authors: Gaspar Reynés, Vicenta Martínez-Sales, Virtudes Vila, Carmen Balañá, Pedro Pérez-Segura, María A. Vaz, Manuel Benavides, Oscar Gallego, Isabel Palomero, Miguel Gil-Gil, Tania Fleitas, Encarnación Reche

Institutions: Hospital General Universitario Gregorio Marañón, Hospital Clínico San Carlos, Hospital Universitari i Politècnic La Fe, Hospital Clínico Universitario de Valencia, Institut Català d'Oncologia, Hospital Universitario Ramón y Cajal, Hospital Regional Universitario de Málaga, Hospital de Sant Pau, Institut d'Investigació Biomédica de Bellvitge

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2313882001

FWCI: 0.599

Cites: 29

Cited by: 14

Related to: 10